Evidence-Based Practice Institute
Seattle, US · Delaware corporation
Founders & leadership
LD
Linda DimeffExecutive Officer, Director
KK
Kelly KoernerDirector
KK
Kris KelsayDirector
Reported raises · per SEC filings
Form D private placements▶$100KraisedJun 2025 · 3 investors · OtherRule 506(b)
▶$100KraisedJun 2025 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kris KelsayDirector
- Linda DimeffExecutive Officer, Director
- Kelly KoernerDirector
- Offering amount
- $500K
- Amount sold
- $100K
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$950KraisedApr 2021 · 15 investors · OtherRule 506(b)
▶$950KraisedApr 2021 · 15 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Linda DimeffExecutive Officer, Director
- Kris KelsayDirector
- Kelly KoernerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $950K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 11 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $319.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $957.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $398K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $2.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $274.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $340.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $184.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.